Lawrence Otto Klein, Chief Executive Officer at Oruka Therapeutics, Inc. (ORKA), sold 75,000 shares at $90.79 ($6.9M) on 2026-09-01, disclosed to the SEC on 2026-09-01.
Scheduled sale ($6.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.79 | 6,604 | $600K | 8.7% |
| 2 | $91.90 | 63,596 | $5.8M | 84.9% |
| 3 | $92.44 | 4,800 | $444K | 6.4% |
| Total | $91.83 avg | 75,000 | $6.9M | 100% |
| Filing → |
| ORKA | SELL | 2026-06-15 | $120K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $71K | — | Filing → |
| CRSP | SELL | 2021-03-25 | $24.1M | — | Filing → |